Total Current Assets - Erasca Inc (NASDAQ:ERAS) - Alpha Spread

Erasca Inc
NASDAQ:ERAS

Watchlist Manager
Erasca Inc Logo
Erasca Inc
NASDAQ:ERAS
Watchlist
Price: 2.97 USD 2.77% Market Closed
Market Cap: 810.3m USD
Have any thoughts about
Erasca Inc?
Write Note

Erasca Inc
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Erasca Inc
Total Current Assets Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Erasca Inc
NASDAQ:ERAS
Total Current Assets
$320.7m
CAGR 3-Years
39%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Current Assets
$33.8B
CAGR 3-Years
9%
CAGR 5-Years
17%
CAGR 10-Years
7%
Gilead Sciences Inc
NASDAQ:GILD
Total Current Assets
$12.3B
CAGR 3-Years
-4%
CAGR 5-Years
-18%
CAGR 10-Years
-2%
Amgen Inc
NASDAQ:AMGN
Total Current Assets
$27.2B
CAGR 3-Years
13%
CAGR 5-Years
-2%
CAGR 10-Years
-2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Current Assets
$8.9B
CAGR 3-Years
2%
CAGR 5-Years
14%
CAGR 10-Years
21%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Current Assets
$19.1B
CAGR 3-Years
13%
CAGR 5-Years
23%
CAGR 10-Years
26%

See Also

What is Erasca Inc's Total Current Assets?
Total Current Assets
320.7m USD

Based on the financial report for Dec 31, 2023, Erasca Inc's Total Current Assets amounts to 320.7m USD.

What is Erasca Inc's Total Current Assets growth rate?
Total Current Assets CAGR 3Y
39%

Over the last year, the Total Current Assets growth was -28%. The average annual Total Current Assets growth rates for Erasca Inc have been 39% over the past three years .

Back to Top